Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome--an update of treatment modalities and pathophysiological cognition.
Refsum's disease is a complex and difficult to diagnose storage disease caused by complex autosomal recessive peroxisomal disorder in which mutations of phytanolyl/pristanoyl-CoA-hydroxilase are the main cause. Poorly metabolised phytanic acid (PA), pristanic acid (PrA) and picolenic acid (PiA) accumulates in fatty tissues, myelin sheaths, heart, kidneys and retina, leading to retinitis pigmentosa, peripheral dissociative polyneuropathy, cerebellar ataxia ("sailors" walk), renal, cardiac and liver impairment. 65% of plasma PA and PrA is localized within VLDL, LDL and HDL lipoprotein particles. Dietary restriction of PA is mostly not sufficient to prevent acute attacks and stabilize the progressive course. LDL and VLDL bound PA/PrA can be effectively eliminated from plasma with extracorporal LDL-apheresis using membrane differential filtration. Mostly additive malnutrition will become worse the clinical picture. Latest experience with black cumin oil (nigella sativa) in a dose of 3 g/day shows a support and a regression of some malnutrition effects in PA restricted dietary and a supportive effect to MDF.
Straube
R
R
Department of Nephrology/Dialysis, General Hospital, Center for Nephrology and Extracorporal Therapy Bochum and Rosenheim, Apheresis Research Institute Cologne, Lüdenscheid/University of Bonn, Ludenscheid, Germany. Dr-Richard-Straube@t-online.de
Gäckler
D
D
Thiele
A
A
Muselmann
L
L
Kingreen
H
H
Klingel
R
R
D001781:Blood Component Removal / Q000379:methods*; D004200:Diseases in Twins; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005374:Filtration / Q000379:methods*; D006801:Humans; D050356:Lipid Metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008875:Middle Aged; D009154:Mutation; D010831:Phytanic Acid / Q000378:metabolism; D010848:Picolinic Acids / Q000378:metabolism; D012035:Refsum Disease / Q000097:blood* / Q000628:therapy*
D005227:Fatty Acids; D008077:Lipoproteins, LDL; D010848:Picolinic Acids; D010831:Phytanic Acid; C002844:pristanic acid; C030614:picolinic acid